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Moyamoya disease is an occlusive intracranial arteriopathy
owing to intimal hyperplasia with formation of abnormal
cerebrovascular collateral networks; however, the etiology re-
mains unclear. Although this disease is known to be associated
with renovascular hypertension, it is extremely rare for it to
be associated with stenoses of the coronary arteries. We herein
described a case of a 56-year-old female with angina and
asymptomatic moyamoya disease. We performed off-pump
coronary artery bypass grafting (OPCAB) to avoid cardio-
pulmonary bypass and the risk of intraoperative hypotension.
Conventional coronary artery bypass grafting has a potential
risk of brain ischemia in moyamoya patients, but OPCAB may
avoid this perioperative cerebral ischemic complication.
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INTRODUCTION
Moyamoya disease is a progressive cerebrovas-
cular occlusive disease, occurring predominantly
in the Northeastern Asian countries. Although the
etiology remains unclear, it is characterized by
intracranial stenosis or occlusion of the internal
carotid arteries, with bilateral abnormal vascular
networks at the base of the brain.
1 Clinically,
ischemic events occur mainly in childhood, while
hemorrhagic events occur in adulthood.
2 Thus,
moyamoya disease has a bimodal incidence. In the
literature, extracranial vascular involvement has
been reported mainly in the renal artery.
3
However, coronary artery involvement among
patients with moyamoya disease is extremely rare.
Such patients have a potential risk of periopera-
tive brain ischemia if they require on-pump coro-
nary artery bypass grafting (CABG). The recent
advanced technique of off-pump coronary artery
bypass grafting (OPCAB) can reduce the risk of
complications by cardiopulmonary bypass (CPB).
We successfully performed OPCAB on a patient
who had coronary artery stenosis with moyamoya
disease.
CASE REPORT
A 56-year-old female was referred to our
hospital for recent effort aggravated angina. She
had no history of hypertension. Approximately
three years prior to admission, she was diagnosed
with moyamoya disease at a check-up for general
weakness at another institution. She had typical
findings of angiographic features of definite type
of Moyamoya disease (Fig. 1).
4 One year after the
diagnosis, she developed effort angina. Coronary
angiography, performed at another hospital, re-
vealed triple vessel disease. This coronary stenosis
was treated by balloon angioplasty and stenting.
However, these procedures failed to relieve symp-
toms, and the patient was referred to us for
CABG. Neurologic examination showed no ab-
normal findings. Laboratory examination demon-
strated no evidence of diabetes mellitus or hyper-
lipidemia. In consideration of the moyamoya
disease, we used OPCAB in order to avoid the
risk of brain ischemia associated with CPB. Intrao-
perative observation indicated that the stenoses
were caused by atherosclerosis. The patient
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received a left internal mammary graft to the left
anterior descending artery, a composite radial
artery free graft to the first obtuse marginal
artery, and a right internal mammary graft to the
right posterolateral branch. During the operation,
systolic blood pressure and blood PaCO2 level
were constantly maintained above 130 mmHg
and 35 mmHg, respectively. The operation was
uneventful and there was no perioperative cere-
bral ischemic episode; the patient had a stable
course and was discharged nine days postopera-
tively.
Before discharge, we evaluated graft patency
using multi-slice CT [(M-CT) (Fig. 2)]. M-CT is




Moyamoya disease is a rare entity of unclear
cause that develops predominantly in North-
eastern Asian people. Although this disease is
usually confined to the intracranial cavity, it is
sometimes associated with the extracranial arterial
system, such as the renal or coronary artery.
Although a combination of moyamoya and reno-
vascular hypertension is well described, the asso-
ciation of coronary artery disease and moyamoya
is rare. There is some evidence that it may be a
systemic disease. Aoyage and colleagues showed
that smooth muscle cells explanted from scalp
arteries, which are remote from the arteries
frequently involved, had altered cellular
responses to platelet-derived growth factor in
patients with moyamoya disease.
6 Coronary artery
stenosis in moyamoya disease may be caused
either by fibrous intimal thickening, similar to the
histopatholgical changes of the intracranial
internal carotid arteries or atherosclerosis.
7 In the
previous literature, only twelve cases of moyamoya
and associated coronary artery stenosis, have been
reported.
8 Among them, only three cases under-
went coronary artery bypass grafting, and two of
those had CPB. Only one case had CABG without
CPB; a 56-year-old hypertensive Japanese female
underwent minimally invasive direct CABG
through a left anterior mini-thoracotomy for one
vessel disease.
7 However, our case had complex
triple vessel disease, and required total arterial
revascularization using OPCAB to avoid CPB and
aortic manipulation. It is noteworthy to mention
that our case was different from any other re-
ported case.
CPB in moyamoya patients has a high risk of
decreasing cerebral perfusion pressure due to the
perfusion pressure variability in the initial stages
of CPB and nonpulsatile flow. The risk of hypo-
capnic cerebral vasoconstriction and hypercapnic
cerebral steal is well recognized.
9 The most im-
portant point, for these patients who require coro-
nary artery bypass grafting, is to avoid possible
hypotension and maintain proper management of
blood PaCO2 level. OPCAB can assist in these
situations.
In conclusion, OPCAB is a safe procedure that
avoids the risk of CPB related hypotensive brain
Fig. 1. Angiographic images of the cerebral artery show
the occlusions at the distal site of right ICA and demon-
strate abnormal vascular network.
Fig. 2. Multi-slice 3D reconstruction CT performed 8 days
postoperatively showing a patent grafts. RIMA, right
internal mammary artery; LIMA, left internal mammary
artery; RA, radial artery.Do-Kyun Kim and Kyung-Jong Yoo
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ischemia, for multi-vessel coronary patients with
moyamoya disease.
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